Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Glow Stack Dosage for Youthful Skin: Protocol Comparison

Maintenance (Prevention) 1.5mg daily 2mg daily (10-day pulse) 0.5mg daily 4 weeks Subtle skin texture improvement within 3–4 weeks; measurable collagen density increase at 6–8 weeks Best for individuals under 35 with minimal photoaging; sufficient to maintain

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Maintenance (Prevention)
  • 1.5mg daily
  • 2mg daily (10-day pulse)
  • 0.5mg daily
  • 4 weeks
  • Subtle skin texture improvement within 3–4 weeks; measurable collagen density increase at 6–8 weeks
  • Best for individuals under 35 with minimal photoaging; sufficient to maintain baseline collagen synthesis without aggressive intervention
  • Intensive (Active Correction)
  • 2mg daily
  • 5mg daily (10-day pulse)
  • 1mg daily
  • 8 weeks
  • Visible reduction in fine lines within 4 weeks; improvement in skin elasticity and hydration measurable by corneometry at 6 weeks
  • Recommended for moderate photoaging, loss of dermal thickness, or recovery from ablative procedures; higher dose justified by mechanism saturation research
  • Research (Maximum Effect)
  • 2.5mg daily
  • 10mg daily (20-day pulse)
  • 12 weeks
  • Maximal collagen remodeling at 8–10 weeks; telomere lengthening detectable in peripheral blood draws at 12 weeks
  • Used in clinical research settings; exceeds typical cosmetic application but demonstrates upper bounds of peptide efficacy; not recommended without medical supervision
  • Budget-Conscious
  • Omitted
  • 6 weeks
  • Moderate improvement in wound healing and microcirculation; collagen synthesis increase of approximately 30–40% vs baseline
  • Eliminates epithalon to reduce cost; retains core collagen-stimulating and angiogenic effects; suitable for individuals prioritising affordability over maximal telomere-targeting effects